Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    Open Studies | urology | NIDDK
Show Display Options
Rank Status Study
21 Recruiting Genetic Markers for Focal Segmental Glomerulosclerosis
Conditions: Focal Segmental Glomerulosclerosis;   HIV-Associated Focal Segmental Glomerulosclerosis
Intervention:
22 Recruiting Feasibility Study of Metformin Therapy in ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Drug: Placebo
23 Recruiting Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD)
Conditions: Chronic Kidney Disease (CKD);   End-Stage Renal Disease (ESRD)
Intervention:
24 Recruiting Alkali Therapy in Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Metabolic Acidosis
Interventions: Drug: Sodium bicarbonate;   Drug: Placebo
25 Recruiting Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathy;   Obesity
Intervention:
26 Recruiting Treatment for Calcium Phosphate Kidney Stone Disease
Condition: Calcium Phosphate Kidney Stones
Interventions: Drug: Placebo;   Dietary Supplement: Citric Acid;   Dietary Supplement: Potassium Citrate;   Drug: Indapamide
27 Recruiting Quality of Life in Kidney Stone Patients Undergoing Surgery
Conditions: Kidney Calculi;   Quality of Life
Interventions: Procedure: Ureteroscopy;   Procedure: Percutaneous nephrolithotomy;   Device: Ureteral stent (double-J stent);   Device: Percutaneous nephrostomy tube
28 Recruiting Ultrasound Imaging of Kidney Stones and Lithotripsy
Conditions: Kidney Stones;   Nephrolithiasis;   Urolithiasis;   Ureter Stones
Intervention: Device: Verasonics Data Acquisition System (VDAS)
29 Not yet recruiting Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury
Conditions: Critically Ill;   Acute Kidney Injury
Interventions: Drug: Calcifediol;   Drug: Calcitriol;   Drug: Placebos
30 Recruiting Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Conditions: Nephrotic Syndrome;   Proteinuria;   Autoimmune Disease;   Glomerular Disease;   Membranous Glomerulonephritis
Interventions: Drug: Rituximab Infusion;   Drug: Oral Cyclosporine
31 Recruiting Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Diabetic Kidney Disease;   Albuminuria
Intervention:
32 Recruiting Pathogenesis of Glomerulosclerosis
Conditions: AIDS Associated Nephropathy;   Focal Glomerulosclerosis;   HIV Infections
Intervention:
33 Recruiting Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Conditions: Hypertension;   Chronic Kidney Disease
Intervention:
34 Not yet recruiting Renal Uptake of Fatty Acids (FFA) in Patients With Idiopathic Uric Acid Nephrolithiasis (IUAN)
Condition: Uric Acid Nephrolithiasis
Intervention: Other: Radioactive isotope
35 Recruiting Health-related Quality of Life in Rare Kidney Stone
Conditions: Primary Hyperoxaluria;   Cystinuria;   Adenine Phosphoribosyl Transferase Deficiency;   Dent Disease
Intervention: Other: Health-related Quality of Life in Rare Kidney Stone Wuestionnaire
36 Recruiting Microbiomes of Pelvic Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis;   Chronic Pelvic Pain Syndrome;   Lower Urinary Tract Symptoms;   Overactive Bladder;   Major Depression
Intervention:
37 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
38 Not yet recruiting Lipoic Acid Supplement for Cystine Stone
Condition: Cystinuria
Interventions: Dietary Supplement: Alpha lipoic acid;   Drug: Placebo
39 Recruiting Gut Microbiome and p-Inulin in Hemodialysis
Conditions: End-Stage Renal Disease;   Gut Microbiome Dysbiosis
Intervention: Dietary Supplement: p-inulin
40 Recruiting Bupropion for Depression in ESRD Patients on Hemodialysis
Conditions: Major Depression;   End Stage Renal Disease
Interventions: Drug: Fluoxetine;   Drug: Bupropion

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.